Clinics in Dermatology
Volume 25, Issue 3 , Pages 267-275 , May 2007

Gene-environment interactions in sarcoidosis: challenge and opportunity

  • Daniel A. Culver, DO

      Affiliations

    • Department of Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic, Cleveland, OH 44195 USA
    • Department of Pathobiology, Cleveland Clinic, Cleveland, OH 44195 USA
    • Corresponding Author InformationCorresponding author. Department of Pulmonary, Allergy and Critical Care Medicine Cleveland Clinic Foundation, Cleveland, OH 44195. Tel.: +1 216 444 6508; fax: +1 216 445 8160.
    • ,
  • Lee S. Newman, MD

      Affiliations

    • Department of Preventive Medicine and Biometrics, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
    • Department of Medicine, Division of Allergy and Clinical Immunology, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
    • Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
    • ,
  • Mani S. Kavuru, MD

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Brody School of Medicine, East Carolina University. Greenville, NC, USA

References 

  1. Hunninghake GW, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149–173
  2. Spagnolo P, du Bois RM. Genetics of sarcoidosis. Clin Dermatol. 2007;25:242–249
  3. Ezzie ME, Crouser ED. Considering an infectious etiology of sarcoidosis. Clin Dermatol. 2007;25:259–266
  4. Martinetti M, et al. “The sarcoidosis map”: a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med. 1995;152:557–564
  5. Iannuzzi MC, et al. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. 2003;167:1225–1231
  6. Rossman MD, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73:720–735
  7. Rybicki BA, et al. Sarcoidosis and granuloma genes: a family-based study in African-Americans. J Eur Respir. 2004;24:251–257
  8. Iannuzzi MC, et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. 2005;6:509–518
  9. Schurmann M, et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med. 2001;164:840–846
  10. Spagnolo P, et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med. 2005;172:721–728
  11. Berlin M, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 1997;156:1601–1605
  12. Tiret L. Gene-environment interaction: a central concept in multifactorial diseases. Proc Nutr Soc. 2002;61:457–463
  13. Brandt B, et al. Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene. Cancer Res. 2004;64:7–12
  14. Li YF, et al. Associations of tumor necrosis factor G-308A with childhood asthma and wheezing. Am J Respir Crit Care Med. 2006;173:970–976
  15. Martinez FD. Gene-environment interactions in asthma and allergies: a new paradigm to understand disease causation. Immunol Allergy Clin North Am. 2005;25:709–721
  16. van Boven HH, et al. Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency. Blood. 1999;94:2590–2594
  17. Fumeron F, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest. 1995;96:1664–1671
  18. Mucci LA, et al. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med. 2001;249:477–493
  19. Grigorenko EL. The inherent complexities of gene-environment interactions. J Gerontol B Psychol Sci Soc Sci. 2005;60(Spec No 1):53–64
  20. Talmud PJ. How to identify gene-environment interactions in a multifactorial disease: CHD as an example. Proc Nutr Soc. 2004;63:5–10
  21. Hayward NK. Genetics of melanoma predisposition. Oncogene. 2003;22:3053–3062
  22. Camarena A, et al. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med. 2001;163:1528–1533
  23. McSharry C, Banham SW, Boyd G. Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clin Allergy. 1985;15:487–494
  24. Scanlon EF, et al. Influence of smoking on the development of lung metastases from breast cancer. Cancer. 1995;75:2693–2699
  25. Kraft P, Hunter D. Integrating epidemiology and genetic association: the challenge of gene-environment interaction. Philos Trans R Soc Lond B Biol Sci. 2005;360:1609–1616
  26. Vineis P. A self-fulfilling prophecy: are we underestimating the role of the environment in gene-environment interaction research?. Int J Epidemiol. 2004;33:945–946
  27. Wang Y, Localio R, Rebbeck TR. Evaluating bias due to population stratification in epidemiologic studies of gene-gene or gene-environment interactions. Cancer Epidemiol Biomarkers Prev. 2006;15:124–132
  28. Kauffmann F. Post-genome respiratory epidemiology: a multidisciplinary challenge. J Eur Respir. 2004;24:471–480
  29. Rybicki BA, et al. Familial aggregation of sarcoidosis. A Case-Control Etiologic Study of Sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164:2085–2091
  30. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!. Am J Epidemiol. 1996;144:207–213
  31. Davey Smith G, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003;32:1–22
  32. Thomas DC, Conti DV. Commentary: the concept of ‘Mendelian randomization’. Int J Epidemiol. 2004;33:21–25
  33. Richter-Hintz D, et al. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. J Invest Dermatol. 2003;120:765–770
  34. Kramer U, Esser C. Cigarette smoking, metabolic gene polymorphism, and psoriasis. J Invest Dermatol. 2006;126:693–694[Author reply 695]
  35. Padyukov L, et al. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50:3085–3092
  36. Klareskog L, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38–46
  37. Dubaniewicz A, et al. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur J Hum Genet. 2005;13:829–834
  38. Pabst S, et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol. 2006;143:420–426
  39. Niimi T, et al. Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med. 1999;160:1107–1109
  40. Wilkinson RJ, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case-control study. Lancet. 2000;355:618–621
  41. Song Z, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005;201:755–767
  42. Rybicki BA, et al. Heterogeneity of familial risk in sarcoidosis. Genet Epidemiol. 1996;13:23–33
  43. Rybicki BA, et al. Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect. 1998;13:166–173
  44. Culver DA, Dweik RA. Chronic beryllium disease. Clin Pulm Med. 2003;10:72–79
  45. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science. 1993;262:242–244
  46. Amicosante M, et al. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69. Hum Immunol. 2001;62:686–693
  47. Maier LA, et al. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003;171:6910–6918
  48. Grunewald J, et al. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax. 2002;57:348–352
  49. Newman LS, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–1330
  50. Smith PG, Day NE. The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol. 1984;13:356–365
  51. Hirschhorn JN, et al. A comprehensive review of genetic association studies. Genet Med. 2002;4:45–61
  52. Garcia-Closas M, Lubin JH. Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am J Epidemiol. 1999;149:689–692
  53. Garcia-Closas M, Rothman N, Lubin J. Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size. Cancer Epidemiol Biomarkers Prev. 1999;8:1043–1050
  54. Barnes KC. Genetic epidemiology of health disparities in allergy and clinical immunology. J Allergy Clin Immunol. 2006;117:243–254[Quiz 255-6]
  55. Nickel RG, et al. Determination of Duffy genotypes in three populations of African descent using PCR and sequence-specific oligonucleotides. Hum Immunol. 1999;60:738–742
  56. Kuffner T, et al. HLA class II and TNF genes in African Americans from the Southeastern United States: regional differences in allele frequencies. Hum Immunol. 2003;64:639–647
  57. Bonilla C, et al. Admixture in the Hispanics of the San Luis Valley, Colorado, and its implications for complex trait gene mapping. Ann Hum Genet. 2004;68(Pt 2):139–153
  58. Moller DR, Chen ES. Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?. Am J Respir Cell Mol Biol. 2002;27:391–395
  59. Rybicki BA. Genetic epidemiological approaches to the study of lung disease. Semin Respir Crit Care Med. 2003;24:137–150

PII: S0738-081X(07)00058-2

doi: 10.1016/j.clindermatol.2007.03.005

Clinics in Dermatology
Volume 25, Issue 3 , Pages 267-275 , May 2007

Article Tools

* Image Usage & Resolution